EPISODE · Sep 21, 2023 · 37 MIN
Why Are Mindy Kaling and Kim Kardashian So Thin?
from Infamous · host Campside Media / Sony Music Entertainment
In a matter of months, the diabetes drug Ozempic has become a household name, and the Danish pharmaceutical company that produces it has achieved a market cap that exceeds the size of its country’s economy — all because it can make people really, really skinny. Journalist Jo Piazza joins Vanessa and Natalie to discuss Ozempic, the celebrities who may or may not be taking it, and how this drug may change our world in the future. Click ‘Subscribe’ at the top of the Infamous show page on Apple Podcasts or visit GetTheBinge.com to get access wherever you get your podcasts. A Campside Media & Sony Music Entertainment production. Find more great podcasts from Sony Music Entertainment at sonymusic.com/podcasts Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit podcastchoices.com/adchoices
What this episode covers
In a matter of months, the diabetes drug Ozempic has become a household name, and the Danish pharmaceutical company that produces it has achieved a market cap that exceeds the size of its country’s economy — all because it can make people really, really skinny. Journalist Jo Piazza joins Vanessa and Natalie to discuss Ozempic, the celebrities who may or may not be taking it, and how this drug may change our world in the future. Click ‘Subscribe’ at the top of the Infamous show page on Apple Podcasts or visit GetTheBinge.com to get access wherever you get your podcasts. A Campside Media & Sony Music Entertainment production. Find more great podcasts from Sony Music Entertainment at sonymusic.com/podcasts Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit podcastchoices.com/adchoices
NOW PLAYING
Why Are Mindy Kaling and Kim Kardashian So Thin?
No transcript for this episode yet
Similar Episodes
Jul 15, 2026 ·1m
Jul 12, 2026 ·18m
Jul 11, 2026 ·15m
Jul 9, 2026 ·48m
Jul 5, 2026 ·23m